Consult the Programme
Read this CardioPulse article about CCP.
Eur Heart J (2016) 37(19): 1485-1492 DOI: http://dx.doi.org/10.1093/eurheartj/ehw143
The Systolic Blood Pressure Intervention Trial (SPRINT) was designed to test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal (120mmHg) than currently recommended (140mmHg) could reduce cardiovascular disease (CVD) risk.
Dr. Marc Ferrini from the Council for Cardiology Practice has contributed this review of the Sprint Trial.
Here are the most recent ESC Guidelines.
Access the full list of ESC Guidelines.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved